TABLE 10. Estimated percent using inhaled short acting beta agonists among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey, United States, 2007

State/Territory Current Active
Sample
size±
% SE§ 95% CI Sample
size
% SE 95% CI
Alaska 97 51.2 7.9 (35.7 – 66.7) 114 48.0 7.0 (34.3 – 61.7)
Arizona 165 48.4 6.7 (35.3 – 61.5) 179 44.1 6.5 (31.4 – 56.8)
California 197 55.0 4.7 (45.8 – 64.2) 216 46.7 5.5 (35.9 – 57.5)
Colorado 269 44.7 4.4 (36.1 – 53.3) 291 44.1 4.1 (36.1 – 52.1)
Connecticut 268 47.7 5.3 (37.3 – 58.1) 288 46.1 5.1 (36.1 – 56.1)
District of Columbia 119 45.6 6.1 (33.6 – 57.6) 134 39.2 5.5 (28.4 – 50.0)
Florida 603 51.8 5.0 (42.0 – 61.6) 656 45.4 4.8 (36.0 – 54.8)
Georgia 267 37.2 4.0 (29.4 – 45.0) 301 34.8 3.8 (27.4 – 42.2)
Hawaii 303 48.0 4.4 (39.4 – 56.6) 309 48.2 4.4 (39.6 – 56.8)
Illinois 209 48.0 4.6 (39.0 – 57.0) 228 42.9 4.4 (34.3 – 51.5)
Indiana 305 56.0 4.2 (47.8 – 64.2) 319 56.0 3.9 (48.4 – 63.6)
Iowa 205 50.2 4.9 (40.6 – 59.8) 221 47.6 4.7 (38.4 – 56.8)
Kansas 403 48.6 4.2 (40.4 – 56.8) 425 50.7 4.0 (42.9 – 58.5)
Maine 372 53.6 4.1 (45.6 – 61.6) 389 51.8 4.0 (44.0 – 59.6)
Maryland 298 49.0 4.2 (40.8 – 57.2) 337 43.6 3.9 (36.0 – 51.2)
Massachusetts 180 44.1 6.4 (31.6 – 56.6) 197 42.5 6.0 (30.7 – 54.3)
Michigan 401 60.3 3.8 (52.9 – 67.7) 440 56.2 3.6 (49.1 – 63.3)
Missouri 248 64.9 4.5 (56.1 – 73.7) 249 66.9 4.6 (57.9 – 75.9)
Montana 245 50.5 5.0 (40.7 – 60.3) 252 48.0 5.1 (38.0 – 58.0)
Nebraska 422 52.5 5.6 (41.5 – 63.5) 442 50.8 5.2 (40.6 – 61.0)
Nevada 204 50.3 5.6 (39.3 – 61.3) 224 47.5 5.3 (37.1 – 57.9)
New Hampshire 231 53.1 4.5 (44.3 – 61.9) 249 51.4 4.3 (43.0 – 59.8)
New Mexico 244 65.2 4.1 (57.2 – 73.2) 282 58.0 4.3 (49.6 – 66.4)
New York 285 52.8 4.0 (45.0 – 60.6) 317 48.9 3.9 (41.3 – 56.5)
Ohio 408 45.7 4.5 (36.9 – 54.5) 441 43.2 4.0 (35.4 – 51.0)
Oklahoma 281 54.2 4.4 (45.6 – 62.8) 287 53.0 4.3 (44.6 – 61.4)
Oregon 314 50.5 4.5 (41.7 – 59.3) 340 47.6 4.2 (39.4 – 55.8)
Pennsylvania 217 56.9 5.5 (46.1 – 67.7) 246 53.1 5.1 (43.1 – 63.1)
Texas 266 40.5 5.2 (30.3 – 50.7) 292 41.9 4.5 (33.1 – 50.7)
Utah 219 47.9 4.5 (39.1 – 56.7) 232 44.7 4.3 (36.3 – 53.1)
Vermont 383 51.3 3.5 (44.4 – 58.2) 402 50.8 3.3 (44.3 – 57.3)
Washington 1,540 58.2 2.1 (54.1 – 62.3) 1,698 55.1 2.0 (51.2 – 59.0)
West Virginia 256 53.8 4.4 (45.2 – 62.4) 264 54.1 4.2 (45.9 – 62.3)
Wisconsin 234 62.0 5.0 (52.2 – 71.8) 262 54.8 5.5 (44.0 – 65.6)
34 areas total 10,658 51.3 1.2 (48.9 – 53.7) 11,523 47.7 1.2 (45.3 – 50.1)
Median   50.9       48.0    
Range   37.2-65.2       34.8-66.9    

1 Aged ≥ 18 years

2 “Yes” response to “Do you still have asthma?”

3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma

± Sample size excludes “DK/Refused”

§ Standard error

Confidence interval